FIELD: chemistry.
SUBSTANCE: invention describes novel compounds of general formula in which is or (values of radicals are given in the claim), a method of producing said compounds, a pharmaceutical composition containing said compounds and therapeutic application thereof.
EFFECT: compounds are cysteine protease inhibitors and can be used in medicine.
25 cl, 1 tbl, 41 ex
Title | Year | Author | Number |
---|---|---|---|
NEW TETRACYCLIC CYSTEIN PROTEASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS THEREOF AND APPLICATION THEREOF | 2007 |
|
RU2481349C2 |
NOVEL CYSTEINE PROTEASE INHIBITORS AND THERAPEUTIC APPLICATION THEREOF | 2006 |
|
RU2424234C2 |
SELECTIVE AND REVERSIBLE UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITOR | 2012 |
|
RU2622640C2 |
BENZOFURAN DERIVATIVES | 2004 |
|
RU2328495C2 |
PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII | 2019 |
|
RU2795374C2 |
METHOD OF SYNTHESIS OF DERIVATIVE OF 8-CYCLO-PENTYL-6-ETHYL-3- (SUBSTITUTED)-5,8-DIHYDRO-4H-1,2,3A,7,8-PENTAAZA-AC-INDACENE (VARIANTS) AND INTERMEDIATE COMPOUNDS | 2000 |
|
RU2189985C2 |
PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII | 2016 |
|
RU2729609C2 |
DERIVATIVES OF BETA-AMINO ACID NITRILES | 2001 |
|
RU2245871C2 |
DERIVATIVES OF PYRROLO[3,2-c]PYRIDIN-4-ONE 2-INDOLINONE AS PROTEINKINASE INHIBITORS | 2007 |
|
RU2410387C2 |
DEVICES FOR BLOOD INTAKE, CONTAINING LYSOPHOSPHOLIPASE INHIBITOR | 2012 |
|
RU2623049C2 |
Authors
Dates
2012-01-20—Published
2006-12-05—Filed